Please assess the completion status of the following clinical trial:

Trial Title: Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Norwood-Hamilton Type III vertex, IV, or V~Exclusion Criteria:~* History or evidence of hair loss other than androgenetic alopecia~* Scarring of the scalp~* Use of dutasteride in previous 18 months~* Use of finasteride within previous 12 months~* Hair transplantation or hair weaving within 6 months~* Use of Minoxidil within previous 6 months~* Use of drugs with anti-androgenetic/androgenetic properties within previous 6 months~* Use of Drugs that cause hypertrichosis or hypotrichosis within previous 6 months~* Light or laser treatment of scalp within previous 3 months~* Cosmetic products aimed at improving or correcting signs of hair loss within previous 2 weeks

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- 1mg Finasteride (Type: ACTIVE_COMPARATOR): 1mg finasteride active plus dutasteride placebo, by mouth once daily
- 0.02mg Dutasteride (Type: ACTIVE_COMPARATOR): 0.02mg dutasteride active plus finasteride placebo, by mouth once daily
- 0.1mg Dutasteride (Type: ACTIVE_COMPARATOR): 0.1mg dutasteride active plus finasteride placebo, by mouth once daily
- 0.5mg Dutasteride (Type: ACTIVE_COMPARATOR): 0.5mg dutasteride active plus finasteride placebo, by mouth once daily
- Placebo (Type: PLACEBO_COMPARATOR): 1mg finasteride placebo plus dutasteride placebo, by mouth once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).